Amundi’s PetMed Express PETS Stock Holding History

Amundi’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-734	Closed	-$7.12K	–	2060
2023 Q3	$7.12K	Hold	734	–	–	﹤0.01%	1973
2023 Q2	$10.1K	Sell	734 -2,868	-80%	-$43.1K	﹤0.01%	1987
2023 Q1	$56K	Buy	3,602 +2,868	+391%	+$54K	﹤0.01%	1869
2022 Q4	$14.4K	Buy	+734	New	+$14.6K	﹤0.01%	1824
2021 Q3	–	Sell	-95,454	Closed	-$3.04M	–	1615
2021 Q2	$3.04M	Buy	+95,454	New	+$3.03M	﹤0.01%	1095

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's PETS Position: Q4 2023 in Review

Amundi sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 734 shares — an estimated $7.12K sold.

Amundi first reported a position in PETS in Q2 2021 and held it in 5 quarters. The position peaked at $3.04M in Q2 2021. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

Amundi reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
Amundi sold 734 PetMed Express shares in Q4 2023, an estimated $7.12K.
Amundi first reported a position in PetMed Express in Q2 2021 and held it in 5 quarters.
Amundi's PetMed Express position peaked at $3.04M in Q2 2021.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.